AI-Crafted diet supplement takes on type 2 diabetes

NCT ID NCT07622628

Recruiting now Disease control Sponsor: ENBIOSIS BIOTECHNOLOGIES Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jul 29, 2026 · Updated 3 times

Summary

This study tests whether a special nutritional supplement, designed using artificial intelligence, can help adults with type 2 diabetes lower their blood sugar over 24 weeks. One hundred participants will receive either the active supplement or a placebo, alongside their usual diabetes care. The main goal is to see if the supplement leads to a greater drop in HbA1c, a key blood sugar marker.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: microbiome-targeted oral food supplement
What this could lead to: If it works, this could point toward a simple dietary supplement to help manage blood sugar in type 2 diabetes.
What could go wrong: This is a small early proof-of-concept study with only 100 participants, so results may not be conclusive or generalizable. The supplement is fixed and not personalized during the trial.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES MELLITUS, TYPE 2 TYPE 2 DIABETES

Contacts and locations

Locations

Bakırçay University Faculty of Medicine Endocrinology Department
RECRUITING

Izmir, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.